Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children

Kanra, G; Marchisio, P; Feiterna-Sperling, C; Gaedicke, G; Lazar, H; Durrer, P; Kursteiner, O; Herzog, C; Kara, A; Principi, N

doi:10.1097/00006454-200404000-00005

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children

Atıf İçin Kopyala

Kanra G., Marchisio P., Feiterna-Sperling C., Gaedicke G., Lazar H., Durrer P., ...Daha Fazla

PEDIATRIC INFECTIOUS DISEASE JOURNAL, cilt.23, sa.4, ss.300-306, 2004 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 23 Sayı: 4
Basım Tarihi: 2004
Doi Numarası: 10.1097/00006454-200404000-00005
Dergi Adı: PEDIATRIC INFECTIOUS DISEASE JOURNAL
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.300-306
Hacettepe Üniversitesi Adresli: Hayır

Özet

Objective. To compare the immunogenicity and safety of a virosome-adjuvanted influenza vaccine (Inflexal V, Berna Biotech, Berne, Switzerland) and a split influenza vaccine (Fluarix; GlaxoSmithMine Biologicals, Rixensart, Belgium) in children.